Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

16 Jan 2015 07:00

RNS Number : 3251C
BrainJuicer Group PLC
16 January 2015
 

 

16 January 2015

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Pre close trading update

 

BrainJuicer Group PLC (AIM: BJU), the innovative international market research agency, today releases the following update on trading during its financial year ended 31 December 2014. The Company will announce its final results on 19 March 2015.

 

Revenue for the year increased by 1% to around £24.6m, an increase of 5% on a constant currency basis. Among our core markets, revenue was flat in the UK, but the US performed well, increasing revenue by some 5-6% at actual exchange rates, and around 10% in constant currencies.

 

The relatively flat overall revenue masks a better performance by our core, and overwhelmingly "Juicy", quantitative products, which delivered growth of some 4% at actual exchange rates as we continued to make encouraging progress with major multinational clients. This was largely offset by a decline in revenue from our lower margin, qualitative Juice Generation business, which is particularly volatile in nature and so not a good indicator of underlying progress.

 

Overheads were well controlled during the year. After factoring in a lower bonus pool than in 2013, and a modest charge for share based payments, pre-tax profits for 2014 are expected to be at least £4m, and so will meet market expectations, compared with £3.6m in the prior year.

 

BrainJuicer was again highly cash generative in 2014, and its financial position remains very strong. £3.9m was returned to shareholders during the year via ordinary and special dividends, share buy-backs and cash settled management equity awards. The Company ended 2014 with a cash balance of £5.3m, compared with £6.2m at the end of 2013. BrainJuicer has no debt.

 

The Company can be found at www.brainjuicer.com

 

- Ends -

 

 

For further information, please contact:

 

BrainJuicer Group PLC

John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVRWRVAAAAAR
Date   Source Headline
25th Sep 20245:15 pmRNSResult of AGM & Notice of H1 Trading Update
12th Aug 20244:15 pmRNSAnnual Report and Notice of AGM
18th Jul 20247:00 amRNSDirector/PDMR Shareholding
12th Jul 20247:00 amRNSFinal Results (correction)
12th Jul 20247:00 amRNSTrading Update
3rd Jul 20247:00 amRNSFinal Results
28th Jun 20243:27 pmRNSUpdate re Director Disclosure
27th Jun 20246:00 pmRNSNotice of Final Results and IMC presentation
24th Jun 20242:52 pmRNSHolding(s) in Company
30th May 20241:04 pmRNSCorrection of Total Voting Rights
28th May 20245:15 pmRNSExercise of Options and Total Voting Rights
28th May 20242:00 pmRNSHolding(s) in Company
24th May 20244:30 pmRNSHolding(s) in Company
24th May 20243:00 pmRNSHolding(s) in Company
24th May 202411:15 amRNSHolding(s) in Company
24th May 202410:30 amRNSHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
24th Jan 20247:00 amRNSTrading Update
12th Dec 202312:51 pmRNSPresentation via Investor Meet Company
6th Dec 20237:00 amRNSChange of Auditor
6th Dec 20237:00 amRNSInterim Results
24th Oct 20237:00 amRNSTrading Update
27th Sep 20236:00 pmRNSResult of AGM
27th Sep 20237:00 amRNSTrading Update
31st Aug 20237:00 amRNSAnnual Report and Notice of AGM
1st Aug 20237:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2023
31st Jul 20232:00 pmRNSPreliminary Results Presentation
13th Jul 20237:30 amRNSTrading update
30th Jun 20239:00 amRNSResolution of Complaint for Trademark Infringement
28th Jun 202311:00 amRNSHolding(s) in Company
3rd May 20233:15 pmRNSFurther re Result of General Meeting
21st Apr 202311:56 amRNSResult of General Meeting
13th Apr 20237:00 amRNSFurther re Requisitioned General Meeting
12th Apr 20237:00 amRNSTrading Update
5th Apr 202310:45 amRNSNotice of Trading Update
24th Mar 20234:00 pmRNSPosting of Circular and Notice of Requisitioned GM
24th Mar 20237:00 amRNSPosting of Circular and Notice of Requisitioned GM
7th Mar 20237:30 amRNSReceipt of Requisition Notice
28th Feb 202312:50 pmRNSCapital Markets Day
23rd Feb 20237:00 amRNSTrading Update
14th Feb 20237:00 amRNSCapital Markets Day
13th Jan 20232:00 pmRNSDirector/PDMR Shareholding
10th Jan 202310:30 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 20224:00 pmRNSDirector/PDMR Shareholding
13th Dec 20226:25 pmRNSDirector/PDMR Shareholding
6th Dec 20224:15 pmRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Results
25th Oct 20227:00 amRNSTrading Update
28th Sep 20226:15 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.